港股早評:恆指低開近1% 科技股普跌 名創優品開漲近15%
格隆匯11月16日丨地緣政治緊張,連續大漲的港股今日低開,恆指跌0.85%,國指跌0.95%,恆生科技指數跌0.87%。盤面上,昨日領銜上漲的大型科技股普跌,京東跌3.4%,百度、阿里巴巴、美團、騰訊、小米皆下跌;汽車股、體育用品股下跌明顯,手機概念股、內險股、建材水泥股普遍走低。另一方面,跨省遊不再與風險區聯動管理,在線旅遊股走強,燃氣股、海運股部分上漲,名創優品繼續高開近15%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.